학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 40건 | 목록 1~10
Academic Journal
In Hipertension y riesgo vascular July-September 2021 38(3):e1-e9
Academic Journal
Chandarlapaty S; Memorial Sloan Kettering Cancer Center, New York, New York.; Dickler MN; Memorial Sloan Kettering Cancer Center, New York, New York.; Perez Fidalgo JA; Hospital Clinico Universitario of Valencia, Biomedical Research Institute INCLIVA, CIBERONC, Valencia, Spain.; Villanueva-Vázquez R; Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.; Giltnane J; Genentech, Inc., South San Francisco, California.; Gates M; Genentech, Inc., South San Francisco, California.; Chang CW; Genentech, Inc., South San Francisco, California.; Cheeti S; Genentech, Inc., South San Francisco, California.; Fredrickson J; Genentech, Inc., South San Francisco, California.; Wang X; Genentech, Inc., South San Francisco, California.; Collier A; Genentech, Inc., South San Francisco, California.; Moore HM; Genentech, Inc., South San Francisco, California.; Metcalfe C; Genentech, Inc., South San Francisco, California.; Lauchle J; Genentech, Inc., South San Francisco, California.; Humke EW; Genentech, Inc., South San Francisco, California.; Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Stradella A; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Gargallo P; Imegen-A part of Health in Code Group, Paterna (Valencia), Spain.; Cejuela M; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Petit A; Department of Pathology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Bosch-Schips J; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Carbonell P; Imegen-A part of Health in Code Group, Paterna (Valencia), Spain.; Recalde S; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Vethencourt A; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Fernandez-Ortega A; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Falo C; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Gil-Gil M; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Vázquez S; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Obadia V; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Villanueva-Vázquez R; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Soler-Monsó T; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Pathology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Calabria I; Imegen-A part of Health in Code Group, Paterna (Valencia), Spain.; Pernas S; Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. spernas@iconcologia.net.; Breast Cancer Group, Institut d'Investigacio Biomedica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. spernas@iconcologia.net.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Villanueva-Vázquez, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어